Condition
Midazolam Overdose
Total Trials
3
Recruiting
0
Active
0
Completed
2
Success Rate
66.7%-20% vs avg
Key Insights
Highlights
Success Rate
67% trial completion
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 87/100
Termination Rate
33.3%
1 terminated out of 3 trials
Success Rate
66.7%
-19.8% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 2 completed with results
Key Signals
67% success
Data Visualizations
Phase Distribution
3Total
Not Applicable (2)
Early P 1 (1)
Trial Status
Completed2
Terminated1
Trial Success Rate
66.7%
Benchmark: 86.5%
Based on 2 completed trials
Clinical Trials (3)
Showing 3 of 3 trials
NCT05334537Not ApplicableCompleted
Effect of Aromatherapy on Perioperative Anxiety Level in Cesarean Sections
NCT03049293Early Phase 1TerminatedPrimary
Measurement of Midazolam Levels in Follicular Fluid
NCT03406936Not ApplicableCompleted
Sedation and Ease of Weaning From Mechanical Ventilation
Showing all 3 trials